Claudia Pérez-Carretero (Claudia Pérez Carretero)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Photodynamic Therapy

Chronic Lymphocytic Leukemia

Top Venues

American journal of hematology

Diagnostics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Claudia Pérez-Carretero, Teresa González, Miguel Quijada Álamo, Gian Matteo Rigolin, Adrian Dubuc, Ángela Villaverde Ramiro, Alberto Rodríguez-Sánchez, Araceli Rubio, Julio Dávila-Valls, Mª Jesús Vidal, Isabel González-Gascón Y Marín, José-Ángel Hernández-Rivas, Rocío Benito, Virginia Volpe, Matthew S Davids, Jeremy S Abramson, Antonio Cuneo, Paola Dal Cin, Ana Eugenia Rodríguez Vicente, Jesús María Hernández-Rivas
Chronic lymphocytic leukemia patients with chromosome 6q deletion as the sole cytogenetic abnormality display a high frequency of RPS15 mutations and have a poor prognosis. American journal of hematology 99 (9) (2024)
Claudia Pérez-Carretero, Teresa González, Miguel Quijada Álamo, Gian Matteo Rigolin, Adrian Dubuc, Ángela Villaverde Ramiro, Alberto Rodríguez-Sánchez, Araceli Rubio, Julio Dávila-Valls, Mª Jesús Vidal, Isabel González-Gascón Y Marín, José-Ángel Hernández-Rivas, Rocío Benito, Virginia Volpe, Matthew S Davids, Jeremy S Abramson, Antonio Cuneo, Paola Dal Cin, Ana Eugenia Rodríguez Vicente, Jesús María Hernández-Rivas
Chronic lymphocytic leukemia patients with chromosome 6q deletion as the sole cytogenetic abnormality display a high frequency of RPS15 mutations and have a poor prognosis. American journal of hematology (2024)
Isabel González-Gascón Y Marín, Mónica Ballesteros-Andrés, Sara Martínez-Flores, Ana-E Rodríguez-Vicente, Claudia Pérez-Carretero, Miguel Quijada-Álamo, Alberto Rodríguez-Sánchez, Jose-Ángel Hernández-Rivas
The Five "Ws" of Frailty Assessment and Chronic Lymphocytic Leukemia: Who, What, Where, Why, and When. Cancers 15 (17) (2023)
Claudia Pérez-Carretero, María Hernández-Sánchez, Teresa González, Miguel Quijada-Álamo, Marta Martín-Izquierdo, Sandra Santos-Mínguez, Cristina Miguel-García, María-Jesús Vidal, Alfonso García-De-Coca, Josefina Galende, Emilia Pardal, Carlos Aguilar, Manuel Vargas-Pabón, Julio Dávila-Valls, Isabel Gascón-Y-Marín, José-Ángel Hernández-Rivas, Rocío Benito, Jesús María Hernández-Rivas, Ana Eugenia Rodríguez Vicente
TRAF3 alterations are frequent in del-3'IGH chronic lymphocytic leukemia patients and define a specific subgroup with adverse clinical features. American journal of hematology 97 (7) (2022)
Claudia Pérez-Carretero, Isabel González-Gascón Y Marín, Ana Eugenia Rodríguez Vicente, Miguel Quijada-Álamo, Jose-Ángel Hernández-Rivas, María Hernández-Sánchez, Jesús María Hernández-Rivas
The Evolving Landscape of Chronic Lymphocytic Leukemia on Diagnosis, Prognosis and Treatment. Diagnostics (Basel, Switzerland) 11 (5) (2021)
Isabel González-Gascón Y Marín, Carolina Muñoz-Novas, Ana Eugenia Rodríguez Vicente, Miguel Quijada-Álamo, María Hernández-Sánchez, Claudia Pérez-Carretero, Victoria Ramos-Ascanio, José-Ángel Hernández-Rivas
From Biomarkers to Models in the Changing Landscape of Chronic Lymphocytic Leukemia: Evolve or Become Extinct. Cancers 13 (8) (2021)